Inhibiting Th1/2 cells influences hepatic capillarization by adjusting sinusoidal endothelial fenestrae through

Yuesi Zhong1, Mingxing Xu1, Jingxiong Hu1

  • 1Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong, China.

Aging
|February 3, 2021
PubMed

Insights

T helper 1 (Th1) and Th2 cells play distinct roles in liver fibrosis by influencing hepatic capillarization. Their interactions with liver sinusoidal endothelial cells (LSECs) are mediated by the Rho-ROCK-myosin pathway, affecting liver health.

Area of Science:

  • Immunology
  • Hepatology
  • Cell Biology

Background:

  • CD4+ T cells are crucial in chronic liver diseases.
  • Hepatic capillarization is a hallmark of liver fibrosis.
  • The specific roles of Th1 and Th2 cells in this process are not well understood.

Purpose of the Study:

  • To investigate the roles of Th1 and Th2 cells in liver fibrosis.
  • To explore the interactions between Th1/Th2 cells and LSECs.
  • To determine the impact of these interactions on hepatic capillarization.

Main Methods:

  • Utilized a well-established fibrotic rat model.
  • Conducted in vitro and in vivo experiments.
  • Employed inhibitory antibodies to block Th1/Th2 cell and LSEC interactions.
  • Assessed hepatic capillarization and Rho-ROCK-myosin pathway activation.

Main Results:

  • Inhibiting Th2 cell-LSEC interaction restored fenestrae and reduced capillarization.
  • Inhibiting Th1 cell-LSEC interaction showed opposite effects.
  • Th1 cell inhibition increased Rho and myosin light chain phosphorylation; Th2 inhibition decreased it.

Conclusions:

  • Th1 and Th2 cells differentially regulate hepatic capillarization in liver fibrosis.
  • The Rho-ROCK-myosin signaling pathway likely mediates these effects.
  • Targeting Th1/Th2 cell-LSEC interactions could be a therapeutic strategy for liver fibrosis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
101
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.3K